Detalhe da pesquisa
1.
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia.
Hum Mol Genet
; 31(6): 929-941, 2022 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622282
2.
See Elegans: Simple-to-use, accurate, and automatic 3D detection of neural activity from densely packed neurons.
PLoS One
; 19(3): e0300628, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517838
3.
Phenotypic Assessment of Pathogenic Variants in GNAO1 and Response to Caffeine in C. elegans Models of the Disease.
Genes (Basel)
; 14(2)2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36833246
4.
The recurrent pathogenic Pro890Leu substitution in CLTC causes a generalized defect in synaptic transmission in Caenorhabditis elegans.
Front Mol Neurosci
; 16: 1170061, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37324589
5.
A Shearless Microfluidic Device Detects a Role in Mechanosensitivity for AWCON Neuron in Caenorhabditis elegans.
Adv Biol (Weinh)
; 5(9): e2100927, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423577
6.
C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples.
Sci Rep
; 11(1): 17133, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34429473